6.
Mio C, Bulotta S, Russo D, Damante G
. Reading Cancer: Chromatin Readers as Druggable Targets for Cancer Treatment. Cancers (Basel). 2019; 11(1).
PMC: 6356452.
DOI: 10.3390/cancers11010061.
View
7.
Fraschilla I, Jeffrey K
. The Speckled Protein (SP) Family: Immunity's Chromatin Readers. Trends Immunol. 2020; 41(7):572-585.
PMC: 8327362.
DOI: 10.1016/j.it.2020.04.007.
View
8.
Bloch D, Nakajima A, Gulick T, Chiche J, Orth D, de la Monte S
. Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator. Mol Cell Biol. 2000; 20(16):6138-46.
PMC: 86089.
DOI: 10.1128/MCB.20.16.6138-6146.2000.
View
9.
Staal F, Luis T, Tiemessen M
. WNT signalling in the immune system: WNT is spreading its wings. Nat Rev Immunol. 2008; 8(8):581-93.
DOI: 10.1038/nri2360.
View
10.
Li X, Li G, Li L, Gao B, Niu X, Wang Y
. SP140 inhibitor suppressing TRIM22 expression regulates glioma progress through PI3K/AKT signaling pathway. Brain Behav. 2024; 14(3):e3465.
PMC: 10928341.
DOI: 10.1002/brb3.3465.
View
11.
Yamazaki J, Taby R, Vasanthakumar A, Macrae T, Ostler K, Shen L
. Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia. Epigenetics. 2012; 7(2):201-7.
PMC: 3335912.
DOI: 10.4161/epi.7.2.19015.
View
12.
Ji D, Witt K, Kotov D, Margolis S, Louie A, Chevee V
. Role of the transcriptional regulator SP140 in resistance to bacterial infections via repression of type I interferons. Elife. 2021; 10.
PMC: 8248984.
DOI: 10.7554/eLife.67290.
View
13.
Karaky M, Fedetz M, Potenciano V, Andres-Leon E, Codina A, Barrionuevo C
. SP140 regulates the expression of immune-related genes associated with multiple sclerosis and other autoimmune diseases by NF-κB inhibition. Hum Mol Genet. 2018; 27(23):4012-4023.
DOI: 10.1093/hmg/ddy284.
View
14.
Li H, Durbin R
. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14):1754-60.
PMC: 2705234.
DOI: 10.1093/bioinformatics/btp324.
View
15.
Jostins L, Ripke S, Weersma R, Duerr R, McGovern D, Hui K
. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012; 491(7422):119-24.
PMC: 3491803.
DOI: 10.1038/nature11582.
View
16.
Bata N, Chaikuad A, Bakas N, Limpert A, Lambert L, Sheffler D
. Inhibitors of the Hippo Pathway Kinases STK3/MST2 and STK4/MST1 Have Utility for the Treatment of Acute Myeloid Leukemia. J Med Chem. 2021; 65(2):1352-1369.
PMC: 10149138.
DOI: 10.1021/acs.jmedchem.1c00804.
View
17.
Sharma M, Pruitt K
. Wnt Pathway: An Integral Hub for Developmental and Oncogenic Signaling Networks. Int J Mol Sci. 2020; 21(21).
PMC: 7663720.
DOI: 10.3390/ijms21218018.
View
18.
Suzuki K, Nakajima H, Saito Y, Saito T, Leonard W, Iwamoto I
. Janus kinase 3 (Jak3) is essential for common cytokine receptor gamma chain (gamma(c))-dependent signaling: comparative analysis of gamma(c), Jak3, and gamma(c) and Jak3 double-deficient mice. Int Immunol. 2000; 12(2):123-32.
DOI: 10.1093/intimm/12.2.123.
View
19.
Chen E, Tan C, Kou Y, Duan Q, Wang Z, Meirelles G
. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013; 14:128.
PMC: 3637064.
DOI: 10.1186/1471-2105-14-128.
View
20.
Di Bernardo M, Crowther-Swanepoel D, Broderick P, Webb E, Sellick G, Wild R
. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet. 2008; 40(10):1204-10.
DOI: 10.1038/ng.219.
View